News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck KGaA (MKGAF.PK) Profit Helped by Rebif Sales, Forex



8/15/2012 6:44:09 AM

German drugmaker Merck KGaA (MRCG.DE) nudged its earnings outlook higher after beating quarterly expectations, helped by higher sales of multiple sclerosis drug Rebif and a strong dollar. Merck said on Tuesday it had seen a "solid top-line performance in all divisions driven especially by strong organic sales growth from (prescription drug unit) Merck Serono and favourable foreign exchange rates". Second-quarter adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) rose 14 percent to 747 million euros ($922 million), compared with a forecast for 706 million in a Reuters poll.

Read at Reuters
Read at RTT News
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES